Related Experiment Video
Updated: May 31, 2026
12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Immunity against Staphylococcus aureus cutaneous infections.
1Department of Medicine, Division of Dermatology, University of California Los Angeles (UCLA), 52-121 Center for Health Sciences, 10833 Le Conte Avenue, Los Angeles, California 90095, USA. lloydmiller@mednet.ucla.edu
Nature Reviews. Immunology
|July 2, 2011
Summary
Staphylococcus aureus skin infections are a major problem. Understanding interleukin-1 (IL-1) and IL-17 immune responses is key to developing vaccines and therapies against antibiotic-resistant strains.
Area of Science:
- Immunology
- Dermatology
- Microbiology
Background:
- Cutaneous and soft tissue infections caused by Staphylococcus aureus present significant clinical challenges.
- The rise of antibiotic-resistant strains necessitates alternative treatment strategies like vaccines and immunotherapy.
- Understanding protective immune mechanisms against S. aureus skin infections is crucial.
Purpose of the Study:
- To review recent discoveries regarding immune responses in S. aureus skin infections.
- To discuss the role of interleukin-1 (IL-1) and IL-17 in host defense.
- To explore the potential impact of these insights on developing immune-based therapies and vaccines.
Main Methods:
- This review synthesizes findings from recent immunological and microbiological research.
- It focuses on the mechanisms of neutrophil recruitment to cutaneous infection sites.
- The review discusses the implications of identified immune pathways for therapeutic development.
Main Results:
- Interleukin-1 (IL-1) and IL-17 mediated immune responses are critical for neutrophil recruitment to the skin during S. aureus infection.
- Neutrophil recruitment is essential for effective host defense and bacterial clearance.
- These cytokines play a pivotal role in controlling S. aureus skin infections.
Conclusions:
- IL-1 and IL-17 pathways are vital for protective immunity against Staphylococcus aureus skin infections.
- Targeting these immune responses holds promise for developing novel prophylactic vaccines.
- Immune-based therapies targeting IL-1 and IL-17 could offer alternatives to antibiotics for S. aureus infections.
Related Concept Videos
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:31Defense Against Bacterial Pathogens
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:26Defense Mechanism Against Infection
Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
01:27The Skin Microbiota
The human skin serves as a complex ecosystem inhabited by a diverse community of microorganisms, including bacteria, fungi, and viruses. This microbiome plays a critical role in maintaining skin health and defending against pathogenic invaders. The composition of microbial communities varies significantly across different regions of the body, influenced primarily by the local levels of moisture and sebum.Regional Variation in Skin MicrobiotaCutibacterium acnes predominantly colonizes sebaceous...